Direction, evidence grade, and study type are AI-generated labels (gpt-5-mini), not human-verified. Syntheses are LLM-written. "Tensions" are machine-detected candidates, not confirmed contradictions. A research-acceleration tool, not peer review.
How this is built →
1Distinct papers
0Unique collaborators
1/1OpenAlex citation coverage
Publication span: 2026. Corpus fetch span: 2026.
Identity provenance
Provider IDs
- Openalex:
A5128184426
ORCID evidence
No valid ORCID is stored.
Observed aliases (1)
- Dr. S. Mohamed Rabeek (openalex, provider refresh)
Topics and outcomes in this view
Assessment themes
- Adoption: 1 paper
- Governance: 1 paper
- Innovation: 1 paper
- Labor Markets: 1 paper
- Productivity: 1 paper
Claim outcomes
- Market Structure: 1 paper
- Research Productivity: 1 paper
- Task Completion Time: 1 paper
- Innovation Output: 1 paper
- Output Quality: 1 paper
- Fiscal And Macroeconomic: 1 paper
- Other: 1 paper
- Regulatory Compliance: 1 paper
Papers in the OpenAlex view
Latest stored OpenAlex author observations only. Citation counts below are from the same provider and are not combined with other services.
Scroll the table horizontally to see every column.
| Paper | Author evidence | Date | Provider citations |
|---|---|---|---|
| AI-guided microbial ‘factories’ are shortening design cycles and promising cheaper, greener routes to complex chemicals, but most successes are confined to the lab or pilot scale and persistent scale-up and regulatory hurdles will shape who benefits and how fast.openalex | Dr. S. Mohamed Rabeek provider id |
2026-03-05 | 0 |
Citation observation summary
OpenAlex supplied counts for 1 of 1 papers in this view; 0 are missing. The observed paper counts sum to 0 cumulative citations. This is a coverage summary, not an author score or h-index.